{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:33:50Z","timestamp":1757309630233,"version":"3.37.3"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>According to previous reports, most cases of inflammatory myopathy following messenger RNA (mRNA) vaccination can be classified as idiopathic inflammatory myopathy, particularly dermatomyositis, owing to their similar clinical features and courses. However, some patients have different clinical features and courses. We report a rare case of transient inflammatory myopathy involving the masseter muscle following the third dose of coronavirus disease 2019 (COVID-19) mRNA vaccination. An 80-year-old woman presented with a history of fever and fatigue for 3\u2009months soon after receiving the third COVID-19 mRNA vaccination. Her symptoms progressed to jaw pain and inability to open her mouth. She also experienced mild proximal muscle weakness in the lower limbs but no skin manifestations or daily difficulties. Fat-saturated T2-weighted magnetic resonance imaging showed bilateral high-intensity signals for the masseter and quadriceps muscles. The patient experienced spontaneous resolution of fever and improvement of symptoms 5\u2009months after onset. The timing of the onset of symptoms, the lack of detectable autoantibodies, and the atypical presentation of myopathy in the masseter muscles, in addition to the spontaneous mild course of the disease, all indicate the substantial role of mRNA vaccination in this myopathy. Since then, the patient has been followed up for 4\u2009months without any recurrence of symptoms or any additional treatment. It is important to recognise that the course of myopathy after COVID-19 mRNA vaccination could be different from that of typical idiopathic inflammatory myopathies.<\/jats:p>","DOI":"10.1093\/mrcr\/rxad022","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T16:14:46Z","timestamp":1683994486000},"page":"77-82","source":"Crossref","is-referenced-by-count":3,"title":["Spontaneous resolution of inflammatory myopathy involving the masseter muscle following COVID-19 mRNA vaccination"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-2052","authenticated-orcid":false,"given":"Tomomi","family":"Tada","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Murao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reo","family":"Shiratani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JeongHoon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hideshima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kanki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nachi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shibahara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"},{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7089-3479","authenticated-orcid":false,"given":"Jun","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"},{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Higa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Daini Osaka Police Hospital , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"2023122913270139500_R1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023122913270139500_R2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"2023122913270139500_R3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5114\/reum.2021.111836","article-title":"COVID-19 vaccination-associated anti-Jo-1 syndrome","volume":"59","author":"Gupta","year":"2021","journal-title":"Reumatologia"},{"key":"2023122913270139500_R4","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-022-03266-1","article-title":"Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports","volume":"16","author":"Vutipongsatorn","year":"2022","journal-title":"J Med Case Rep"},{"key":"2023122913270139500_R5","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e32","article-title":"Dermatomyositis following BNT162b2 mRNA COVID-19 vaccination","volume":"37","author":"Gouda","year":"2022","journal-title":"J Korean Med Sci"},{"key":"2023122913270139500_R6","article-title":"Clinicopathological characteristics of inflammatory myositis induced by COVID-19 vaccine (Pfizer-BioNTech BNT162b2): a case report","volume":"37","author":"Kim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"2023122913270139500_R7","article-title":"Dermatomyositis post vaccine against SARS-COV2","volume":"6","author":"Coronel","year":"2022","journal-title":"BMC Rheumatol"},{"key":"2023122913270139500_R8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2022.02.023","article-title":"COVID-19 vaccine-associated dermatomyositis","volume":"23","author":"Wu","year":"2022","journal-title":"JAAD Case Rep"},{"key":"2023122913270139500_R9","article-title":"Clinical and molecular characterization of a rare case of BNT162b2 mRNA COVID-19 vaccine-associated myositis","volume":"10","author":"Magen","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2023122913270139500_R10","article-title":"Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination","author":"Lee","year":"2022","journal-title":"Postgrad Med J"},{"key":"2023122913270139500_R11","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15479","article-title":"Dermatomyositis following COVID-19 vaccination","volume":"35","author":"Venkateswaran","year":"2022","journal-title":"Dermatol Ther"},{"key":"2023122913270139500_R12","first-page":"1","article-title":"New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review","volume":"8","author":"Holzer","year":"2022","journal-title":"Rheumatol Int"},{"key":"2023122913270139500_R13","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1111\/jdv.18211","article-title":"Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination","volume":"36","author":"Kreuter","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023122913270139500_R14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/mrcr\/rxac041","article-title":"Post-COVID-19 vaccination inflammatory syndrome: a case report","volume":"7","author":"Durucan","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"2023122913270139500_R15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/mrcr\/rxac064","article-title":"Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccination","volume":"7","author":"Sugimoto","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"2023122913270139500_R16","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1111\/jdv.18060","article-title":"Two cases of anti-TIF1-\u03b3 antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination","volume":"36","author":"Yoshida","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023122913270139500_R17","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1016\/S2665-9913(21)00312-X","article-title":"Inflammatory myositis after ChAdOx1 vaccination","volume":"3","author":"Maramattom","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2023122913270139500_R18","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1093\/rheumatology\/keac038","article-title":"Dermatomyositis-like rash and inflammatory myopathy after mRNA-1273 vaccination","volume":"61","author":"Kondo","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2023122913270139500_R19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/07853890.2020.1763449","article-title":"Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic","volume":"52","author":"Pulia","year":"2020","journal-title":"Ann Med"},{"key":"2023122913270139500_R20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"key":"2023122913270139500_R21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: the COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J Control Release"},{"key":"2023122913270139500_R22","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108765","article-title":"Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus systemic lupus erythematosus","volume":"229","author":"Ntouros","year":"2021","journal-title":"Clin Immunol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxad022\/50487308\/rxad022.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/8\/1\/77\/54921200\/rxad022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/8\/1\/77\/54921200\/rxad022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T13:27:13Z","timestamp":1703856433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/8\/1\/77\/7161703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,5,11]]},"published-print":{"date-parts":[[2023,12,29]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxad022","relation":{},"ISSN":["2472-5625"],"issn-type":[{"type":"electronic","value":"2472-5625"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,5,11]]}}}